Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension

Study Identifier
190342-011T
CT.gov Identifier
NCT00332345
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Ocular Hypertension
    • Study Drug
  • brimonidine/timolol fixed combination
    • Phase
    Phase 2
    Sex
    Female & Male
    Age
    21+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Clinical diagnosis of glaucoma or ocular hypertension in both eyes * Patient requires IOP-lowering in both eyes
    Exclusion Criteria:
    * Uncontrolled medical conditions * Contraindication to beta-andrenoceptor antagonist or brimonidine therapy

    Protocol Summary

    The purpose of this study is to assess the safety and efficacy of Brimonidine/Timolol Fixed Combination in patients with glaucoma or ocular hypertension

    Study Locations

    Location
    Status
    Location
    Artesia, California, United States
    Status
    Not applicable